{
    "organizations": [],
    "uuid": "e7df9cd2934c944293cd6ebb1e3f2f509c6080c1",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-shandong-buchang-pharmaceuticals-g/brief-shandong-buchang-pharmaceuticals-gets-fda-new-drug-approval-for-metoprolol-succinate-extended-release-tablets-idUSL4N1Q33TF",
    "ord_in_thread": 0,
    "title": "Shandong Buchang Pharmaceuticals gets FDA new drug approval for Metoprolol Succinate Extended-Release Tablets",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 13 (Reuters) - Shandong Buchang Pharmaceuticals Co Ltd :\n* Says its new drug Metoprolol Succinate Extended-Release Tablets gets new drug approval(ANDA) from FDA\n* The drug is developed by the company and a Nantong-based medicine firm Novast\n* The drug is used for treatment of high blood pressure and angina\nSource text in Chinese: goo.gl/4QDByq\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-13T17:59:00.000+02:00",
    "crawled": "2018-02-14T12:25:13.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "shandong",
        "buchang",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "new",
        "drug",
        "metoprolol",
        "succinate",
        "tablet",
        "get",
        "new",
        "drug",
        "approval",
        "anda",
        "fda",
        "drug",
        "developed",
        "company",
        "medicine",
        "firm",
        "novast",
        "drug",
        "used",
        "treatment",
        "high",
        "blood",
        "pressure",
        "angina",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}